Abstract

Clostridium difficile spore germination is critical for the transmission of disease. C. difficile spores germinate in response to cholic acid derivatives, such as taurocholate (TA), and amino acids, such as glycine or alanine. Although the receptor with which bile acids are recognized (germinant receptor) is known, the amino acid co-germinant receptor has remained elusive. Here, we used EMS mutagenesis to generate mutants with altered requirements for the amino acid co-germinant, similar to the strategy we used previously to identify the bile acid germinant receptor, CspC. Surprisingly, we identified strains that do not require co-germinants, and the mutant spores germinated in response to TA alone. Upon sequencing these mutants, we identified different mutations in yabG. In C. difficile, yabG expression is required for the processing of key germination components to their mature forms (e.g., CspBA to CspB and CspA). A defined yabG mutant exacerbated the EMS mutant phenotype. Building upon this work, we found that small deletions in cspA resulted in spores that germinated in the presence of TA alone without the requirement of a co-germinant. cspA encodes a pseudoprotease that was previously shown to be important for incorporation of the CspC germinant receptor. Herein, our study builds upon the role of CspA during C. difficile spore germination by providing evidence that CspA is important for recognition of co-germinants during C. difficile spore germination. Our work suggests that two pseudoproteases (CspC and CspA) likely function as the C. difficile germinant receptors.

Highlights

  • Clostridioides difficile [1,2,3] is a Gram-positive, spore-forming pathogenic bacterium, and has become a leading cause of nosocomial diarrhea in the United States [4, 5]

  • We identified the C. difficile bile acid germinant receptor as the CspC pseudoprotease

  • Our results suggest that two pseudoproteases regulate C. difficile spore germination and provide further evidence that C. difficile spore germination proceeds through a novel spore germination pathway

Read more

Summary

Introduction

Clostridioides difficile (formerly Clostridium difficile) [1,2,3] is a Gram-positive, spore-forming pathogenic bacterium, and has become a leading cause of nosocomial diarrhea in the United States [4, 5]. Due to the broad-spectrum nature of many antibiotics, alterations to the ecology of the colonic microbiome results in the loss of the colonization resistance that is provided by the microbiota. Patients are treated with other, broadspectrum, antibiotics (e.g., vancomycin or fidaxomicin) which treat the actively growing, toxin-producing, vegetative cells [8]. These antibiotics alleviate the primary symptoms of disease, the continued disruption to the colonic microbiome results in frequent CDI recurrence. TcdA (an enterotoxin) and TcdB (a cytotoxin) are endocytosed by the colonic epithelium and inactivate the Rho-family of small GTPases leading to loss of barrier function and inflammation of the colonic epithelium [7]

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.